Free Trial
OTCMKTS:RADLY

Raia Drogasil 3/3/2026 Earnings Report

Raia Drogasil logo
$3.72 -0.15 (-3.93%)
As of 10:18 AM Eastern

Raia Drogasil EPS Results

Actual EPS
N/A
Consensus EPS
$0.04
Beat/Miss
N/A
One Year Ago EPS
N/A

Raia Drogasil Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.28 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Raia Drogasil Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Raia Drogasil Earnings Headlines

Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel
Raia Drogasil SA ADR (RADLY)
See More Raia Drogasil Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Raia Drogasil? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Raia Drogasil and other key companies, straight to your email.

About Raia Drogasil

Raia Drogasil (OTCMKTS:RADLY) is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades. Headquartered in São Paulo, Raia Drogasil has expanded its footprint to all regions of Brazil, with a particularly strong presence in the Southeastern and Northeastern states. This broad geographic coverage positions the company to capture growth in densely populated metropolitan markets as well as emerging local communities.

In response to evolving consumer preferences, Raia Drogasil has developed digital platforms that support online ordering, home delivery and click-and-collect services. The company has also launched a loyalty program that rewards frequent shoppers with discounts, personalized promotions and health-oriented content. These initiatives complement its physical retail network, enhancing customer convenience and fostering deeper engagement.

Raia Drogasil continues to invest in supply chain optimization and partnerships with pharmaceutical and consumer goods suppliers to broaden its product portfolio. The company’s management emphasizes operational efficiency, store modernization and the integration of digital tools, aiming to reinforce its position as Brazil’s foremost pharmacy chain and to meet the evolving needs of Brazilian consumers.

View Raia Drogasil Profile